Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease

Persistent gestational trophoblastic disease is potentially fatal, but the majority of patients are cured with chemotherapy. Any developments in treatment are therefore being directed towards maintaining efficacy and reducing toxicity. We evaluated efficacy and toxicity of methotrexate, etoposide an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dobson, L S, Lorigan, P C, Coleman, R E, Hancock, B W
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2000
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363400/
https://ncbi.nlm.nih.gov/pubmed/10789722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1176
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares